Michelle Brooks

Associate Director, Clinical Data Management at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Michelle Brooks's Colleagues at Alnylam Pharmaceuticals
William MD

Associate Director, Patient Safety and Risk Management

Contact William MD

Robin McDougall

Associate Director, DMPK, Translational PKPD Modeling

Contact Robin McDougall

Heather PharmD

Sr Director, Medical Information & Review, Medical Affairs

Contact Heather PharmD

Jennifer PharmD

Director, US Advertising & Promotion, Regulatory Affairs

Contact Jennifer PharmD

Caitlin Cooper

Director, Business Development

Contact Caitlin Cooper

Rhonda MBA

Regional Business Director

Contact Rhonda MBA

Allison PharmD

Associate Director, Global Patient Safety & Risk Management

Contact Allison PharmD

View All Michelle Brooks's Colleagues
Michelle Brooks's Contact Details
HQ
(617) 551-8200
Location
Company
Alnylam Pharmaceuticals
Michelle Brooks's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Michelle Brooks
Michelle Brooks currently works for Alnylam Pharmaceuticals.
Michelle Brooks's role at Alnylam Pharmaceuticals is Associate Director, Clinical Data Management.
Michelle Brooks's email address is ***@alnylam.com. To view Michelle Brooks's full email address, please signup to ConnectPlex.
Michelle Brooks works in the SaaS industry.
Michelle Brooks's colleagues at Alnylam Pharmaceuticals are William MD, Robin McDougall, Heather PharmD, Jennifer PharmD, Caitlin Cooper, Rhonda MBA, Allison PharmD and others.
Michelle Brooks's phone number is (617) 551-8200
See more information about Michelle Brooks